NCT02778633

Brief Summary

The purpose of this study is to determine fluid responsiveness in critically ill patients by measuring mean systemic filling pressure on the intensive care unit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

May 18, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 20, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 25, 2018

Status Verified

January 1, 2018

Enrollment Period

5.8 years

First QC Date

May 18, 2016

Last Update Submit

January 23, 2018

Conditions

Keywords

Volume responsiveness mean systemic filling pressure

Outcome Measures

Primary Outcomes (1)

  • Mean systemic filling pressure (Pms)

    An increase in mean systemic filling pressure after (self)volume-challenge indicating volume responsiveness of the patient

    1 hour

Secondary Outcomes (1)

  • Heart performance (eH)

    1 hour

Other Outcomes (12)

  • Secondary hemodynamic parameters

    1 hour

  • Secondary hemodynamic parameters

    1 hour

  • Secondary hemodynamic parameters

    1 hour

  • +9 more other outcomes

Study Arms (1)

Sepsis

Patients diagnosed with septic shock, admitted to the intensive care unit, with a good left ventricular ejection fraction without significant co-morbidity are highly eligible for this study. Patients must be equipped with a pulse-contour cardiac output (PICCO)-system with a central venous catheter which will be applied by the intensivist on admission.Patients will be subsequently connected to the hemodynamic monitoring device Navigator™. In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Septic patients on ICU

You may qualify if:

  • Patients must be older than 18 years, and must be equipped with a pulse-contour cardiac output system with a central venous catheter.
  • Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
  • In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.

You may not qualify if:

  • Patients with assist devices (e.g. intra aortic balloon pump, Impella®, ECMO), patients with arrhythmias (either atrial of ventricular) will be excluded from the study.
  • Also, patients with inguinal impairment or contraindications for a passive leg raising will be excluded (such as deep venous thrombosis or elastic compression stocking), head trauma, an increase intra-abdominal pressure suspected by clinical context and examination as well as patients with absolute contraindications for fluid challenge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina Hospital

Eindhoven, North Brabant, 5623 EJ, Netherlands

RECRUITING

MeSH Terms

Conditions

Cardiac Output, High

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jan Bakker, MD, PhD

    Erasmus Medical Center

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD-candidate Intensive Care Unit / resident cardiology

Study Record Dates

First Submitted

May 18, 2016

First Posted

May 20, 2016

Study Start

August 1, 2013

Primary Completion

May 1, 2019

Study Completion

December 1, 2019

Last Updated

January 25, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

No, data remain anonymized within hospital and property of PI.

Locations